Sun, Nov 15, 2026
[Archive]
Volume 18, Issue 3 (September-2026 2026)
Iranian Journal of Blood and Cancer 2026, 18(3): 102-110 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Afaridoon S, Jafariyan Lahijani N, Mehrvar A, Tashvighi M, Mehrvar N, Azarkeivan A. Evaluation of Optimal Blood and Blood Component Consumption in Children with Cancer in MAHAK Hospital. , Iranian Journal of Blood and Cancer. 2026; 18 (3) :102-110
URL: http://ijbc.ir/article-1-1869-en.html
URL: http://ijbc.ir/article-1-1869-en.html
Sahar Afaridoon1 
, Negin Jafariyan Lahijani2 , Azim Mehrvar3 , Maryam Tashvighi3 , Narjes Mehrvar3 , Azita Azarkeivan *4
, Negin Jafariyan Lahijani2 , Azim Mehrvar3 , Maryam Tashvighi3 , Narjes Mehrvar3 , Azita Azarkeivan *4
1- Blood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
2- Mahak Hematology Oncology Research Center (Mahak-HORC), Mahak Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Parvaneh Childhood Cancer Department, Golestan Hospital, Tehran, Iran.
4- Blood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran. ,azazarkeivan@gmail.com
2- Mahak Hematology Oncology Research Center (Mahak-HORC), Mahak Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Parvaneh Childhood Cancer Department, Golestan Hospital, Tehran, Iran.
4- Blood Transfusion Research Centre, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran. ,
Abstract: (34 Views)
Background: Blood transfusion is an essential supportive treatment for children with cancer, but inappropriate or excessive use of blood components may increase risks and resource utilization. This study aimed to evaluate blood and blood component consumption and transfusion-related complications in children with cancer at MAHAK Hospital.
Materials and Methods: This retrospective study included 830 children with cancer who were admitted to MAHAK Hospital. Data on demographic and clinical characteristics, blood component transfusions, transfusion thresholds, and transfusion-related reactions were collected and analyzed using descriptive statistics.
Results: Of the 830 patients, 513 (61.8%) had solid tumors and 317 (38.2%) had non-solid malignancies. PRBC transfusion was recorded for 830 patients, platelet transfusion for 830 patients, and plasma transfusion for 495 patients. Most patients received 1–5 units of PRBCs (64.3%) or platelets (53.3%), while 40.4% received no plasma and 49.6% received 1–5 units. The most frequently recorded transfusion reaction was febrile reaction with PRBCs (12.2%). Allergic reactions were recorded in 3.9% of patients receiving platelets and 1% receiving plasma. Overall, transfusion reactions were less frequently recorded with plasma than with PRBCs or platelets.
Conclusion: The observed pattern of blood component utilization provides a description of transfusion practice in children with cancer at a specialized pediatric hospital. These findings may help inform patient blood management and future evaluations of transfusion practice in this population.
Materials and Methods: This retrospective study included 830 children with cancer who were admitted to MAHAK Hospital. Data on demographic and clinical characteristics, blood component transfusions, transfusion thresholds, and transfusion-related reactions were collected and analyzed using descriptive statistics.
Results: Of the 830 patients, 513 (61.8%) had solid tumors and 317 (38.2%) had non-solid malignancies. PRBC transfusion was recorded for 830 patients, platelet transfusion for 830 patients, and plasma transfusion for 495 patients. Most patients received 1–5 units of PRBCs (64.3%) or platelets (53.3%), while 40.4% received no plasma and 49.6% received 1–5 units. The most frequently recorded transfusion reaction was febrile reaction with PRBCs (12.2%). Allergic reactions were recorded in 3.9% of patients receiving platelets and 1% receiving plasma. Overall, transfusion reactions were less frequently recorded with plasma than with PRBCs or platelets.
Conclusion: The observed pattern of blood component utilization provides a description of transfusion practice in children with cancer at a specialized pediatric hospital. These findings may help inform patient blood management and future evaluations of transfusion practice in this population.
: Original Article |
Subject:
Pediatric Hematology & Oncology
Received: 2026/07/4 | Accepted: 2026/09/26 | Published: 2026/09/30
Received: 2026/07/4 | Accepted: 2026/09/26 | Published: 2026/09/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
- Iranian Journal of Blood and Cancer
- Journal Tel: +989369936116
- Publisher Tel: +982122275917
- Mail: Info@ijbc.ir
